Catalyst Wire Dossier Catalyst Wire Dossier

AMG 706

motesanib · Amgen
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for AMG 706, covering 2011-01-21 to 2018-01-11. Get the full timeline:

Most recent: Clinical Trial Update: AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]

See pricing